Clinical Outcomes Associated With Diltiazem Use in Heart Failure With Reduced Ejection Fraction After Implementation of a Clinical Support System
CONCLUSION AND RELEVANCE: In patients with heart failure with reduced EF, diltiazem use after nonadherence to a CDSS alert resulted in an increased risk of clinical deterioration. This study highlights the need for improved provider adherence to diltiazem clinical decision support systems.PMID:38571388 | DOI:10.1177/10600280241243071
Source: The Annals of Pharmacotherapy - Category: Drugs & Pharmacology Authors: Elizabeth M Foster James C Coons Elena A Puccio Danine Sullinger Rachel Ibrahim Joseph Ibrahim Gavin W Hickey Edward Horn Vincent Mosesso Ryan M Rivosecchi Source Type: research
More News: Atrial Fibrillation | Cardiology | Diltiazem | Drugs & Pharmacology | Heart | Heart Failure | Study